Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?
For patients with suboptimal relief from lifestyle modifications, acid suppressive therapy remains a cornerstone of treatment for gastro-oesophageal reflux disease (GORD). While a great deal of attention is focused on complications of GORD, adequate symptom relief remains an important and practical therapeutic goal. Adequate symptom relief is an achievable and easily measurable endpoint that both restores quality of life and prevents many potential complications.
Jones
M P
MP
Gastroenterology Laboratory, Northwestern University/Northwestern Memorial Hospital, Chicago, Illinois 60611, USA. mpjones@nmh.org
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000517:prevention & control; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000191:economics; D017048:Health Care Costs; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D054328:Proton Pump Inhibitors; D011788:Quality of Life
D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors